It was reported that the patient experienced an arrhythmia that met medical doctor notification (mdn) requirements that was not transmitted during the wear period.The zio at reached the asymptomatic maximum transmissions limit.No adverse events such as death or serious injury are known to have occurred.The device was approaching the maximum transmission limit four days after it was activated.Irhythm contacted the patient¿s healthcare provider (hcp) to notify that the device was reaching the maximum transmission limit.After the third notification attempt, a second device was shipped to the patient.The following day, the hcp contacted irhythm and declined the second monitor to be sent since the patient was already in the hospital for non-cardiac related issues.The first patch device was returned and during preparation of the final report, irhythm became aware of an arrhythmia that occurred four days after the device had reached the maximum transmission limit.As described in product labeling, the zio at device has a maximum threshold of transmitting 100 patient triggers and 500 asymptomatic transmissions during wear.When a patient is approaching the limit for either transmission type, irhythm reaches out to the account to determine whether to send another zio at device to the patient.Patient-triggered symptomatic transmissions are still able to be transmitted beyond this limit by pressing the large central button located on the outer device housing.This event is being reported per 21 cfr 803 as a product problem / malfunction.This report does not constitute an admission by irhythm that the product described in this report has any defects or has malfunctioned.These terms are included in form fda 3500a and are fixed terms for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.
|
It was reported that the patient experienced an arrhythmia that met medical doctor notification (mdn) requirements that was not transmitted during the wear period.Investigation confirmed that the zio at reached the asymptomatic maximum transmissions limit described in the product labeling.The healthcare provider (hcp) account was notified the device was approaching the asymptomatic transmission limit prior to reaching the limit, and a replacement device was dispatched to the patient, according to standard process.No adverse events such as death or serious injury are known to have occurred.
|